<DOC>
	<DOCNO>NCT02837835</DOCNO>
	<brief_summary>Ceftazidime beta-lactam compound exert time-dependent bactericidal effect . Numerous argument favor continuous administration ceftazidime , reason clinical efficacy preserve bacteriological mutation . The investigator report prospective , single-center , parallel-group , randomize , control trial compare two mode administration ceftazidime , namely , continuous administration ( load dose 20 mg/kg body weight follow 60 mg/kg/day ) versus intermittent administration ( 20 mg/kg 30 min every 8 h ) 34 patient ventilator-associated pneumonia due Gram-negative bacillus . The study perform 48 h 13 18 assessment serum ceftazidime continuous-infusion group ( group A ) intermittent-fusion group ( group B ) , respectively . Bronchoalveolar lavage ( BAL ) perform steady state group 44 h determine ceftazidime level epithelial lining fluid . The investigator choose predefined threshold 20 mg/liter serum concentration ceftazidime ecological condition center .</brief_summary>
	<brief_title>Lung Concentrations Ceftazidime Patients With Ventilator-associated Pneumonia</brief_title>
	<detailed_description>Primary objective The main objective study show continuous administration superiority ceftazidime versus intermittent administration , term lung tissue concentration ceftazidime mechanically ventilate patient pneumonia cause bacillus gram negative . Methods Trial Prospective therapeutic trial parallel group , control , randomize , single center compare two method administration ceftazidime ( continuous administration self-pulsed syringe versus discontinuous administration regimens 3 injection per 24 hour ) patient severe pneumonia mechanically ventilate due gram negative bacillus . Population Patients enrol Intensive Care Unit Reims university hospital . All patient meet inclusion criterion respect criterion non-inclusions ( see ) consecutively enrol study obtain consent . The allocation one 2 treatment modality make randomization . Variables parameter collect study : In addition sociodemographic variable , variable inclusion study judgment criterion , different blood urine test collect : 1 . Criteria inclusion non-inclusion ( see ) ; 2 . Outcome : ) concentration cell film ceftazidime ; ii ) serum concentration ceftazidime ; iii ) period serum concentration ceftazidime high 20 mg/l ; 3 . Socio-demographic variable : Age , Gender ; 4 . Blood Assays : Blood gas ; Blood Urea , créatinimémie chemistry panel ; serum protein ; Complete Blood Count ; Beta HCG woman childbearing age ; Liver function test : AST , ALT , GGT , bilirubin , alkaline phosphatase ; 5 . Urinary Assays : Creatinine clearance urinary electrolyte .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<mesh_term>Ceftazidime</mesh_term>
	<criteria>Inclusion Criteria Age &gt; 18 year ; Patients hospitalize general intensive care unit University Hospital Reims ; Nosocomial pneumonia Gramnegative . Weight &gt; 110 kg ; Pregnant breastfeed woman ; Known allergy beta lactam antibiotic ; Renal impairment : clearance &lt; 60 calculated Cockcroft Gault ; Known history pulmonary fibrosis ; Patients include another research protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>